On the GARDP website, find their 2024-2028 strategy. Explain the core purpose of GARDP's unique antibiotic R&D partnership model. Then, identify the 'Maximizing impact' section and list the three main criteria that guide GARDP's disease area strategy, summarizing each criterion.
Navigate to gardp.org. From the homepage, navigate to the 'GARDP Strategy 2024-2028' page via 'Our work' -> 'Our strategy'. Identify the core purpose of GARDP's unique antibiotic R&D partnership model. Scroll down the page to find the section titled 'Maximizing impact'. Identify and list the three criteria guiding GARDP's disease area strategy and their brief summaries. Present the identified purpose and the listed criteria with their summaries.
Successfully navigate to the 'GARDP Strategy 2024-2028' page. Accurately state the core purpose of GARDP’s unique antibiotic R&D partnership model as: 'enabling the right antibiotic treatments to be developed and made available to people who need them'. Accurately list the three main criteria for GARDP's disease area strategy: - Prioritizes serious bacterial infections and sepsis (including neonatal sepsis) and sexually transmitted infections (with a focus on gonorrhoea). - Targets WHO priority pathogens that are responsible for particularly deadly and debilitating drug-resistant infections. - Concentrates its efforts on populations who are disproportionately affected by drug resistance—like newborns, children and women, particularly in low- and middle-income countries.